Meningococcal groups (A/C/Y/W-135) polysaccharide diphtheria toxoid conjugate vaccine (Sanofi Pasteur)

N/A

Report date: 2024/08/16 20:00:38

Base Information

Drug NameMeningococcal groups (A/C/Y/W-135) polysaccharide diphtheria toxoid conjugate vaccine (Sanofi Pasteur)
Drug Alias NameMenactraMCV-4SP-284
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Biological material > Toxoid vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisNeoplasms, Glandular and EpithelialRubella +[13] 
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/01/14
Country/TerritoryCanadaUnited StatesVietnam +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesCanSino Biologics IncSanofi
Inactive CompaniesSanofi PasteurNational Institute Of Allergy And Infectious Diseases (Niaid)Merck Sharp & Dohme LLC
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsMeningitisNeoplasms, Glandular and EpithelialRubella +[11] 

Other Information

ATC CodeJ07AH08
Related LinksN/A